An2 Therapeutics, Inc. · NASDAQ:ANTX

Almitas Capital LLC's stake in An2 Therapeutics, Inc. fell to 4.10% (Schedule 13G/A)

Event Mar 31, 2026 · Filed May 15, 2026

Almitas Capital LLC's stake in An2 Therapeutics, Inc. fell to 4.10%, 1,479,129 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G/A).

Stake
4.10%
Shares
1,479,129
Intent
Passive
What changed
Fell below 5%

The filing in full

HolderStakeShares
Almitas Capital LLC4.10%1,479,129

Source

View original at SEC

Related